Back
Vertex Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here
Buy
71
VRTX
Vertex Pharmaceuticals
Last Price:
321.30
Seasonality Move:
-0.97%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!Vertex Pharmaceuticals Price Quote
$321.30
-0.15 (0.09%)
(Updated: January 28, 2023 at 4:29 AM ET)
Vertex Pharmaceuticals Key Stats
Buy
71
Vertex Pharmaceuticals (VRTX)
is a Buy
Day range:
$319.58 - $323.67
52-week range:
$225.28 - $324.75
Dividend yield:
0%
P/E ratio:
35.66
P/S ratio:
9.54
P/B ratio:
6.33%
Volume:
1.3M
Avg. volume:
1.4M
1-year change:
40.85%
Market cap:
$82.5B
Revenue:
$7.6B
EPS:
$12.68
How Much Does Vertex Pharmaceuticals Make?
-
How Much Are Vertex Pharmaceuticals's Sales Annually?
VRTX Revenues are $7.6B -
How Much Profit Does Vertex Pharmaceuticals's Make A Year?
VRTX net income is $2.3B
Is Vertex Pharmaceuticals Growing As A Company?
-
What Is Vertex Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.18% -
What Is Vertex Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.09%
Vertex Pharmaceuticals Stock Price Performance
-
Did Vertex Pharmaceuticals Stock Go Up Last Month?
Vertex Pharmaceuticals share price went up by 11.88% last month -
Did VRTX's Share Price Rise Over The Last Year?
VRTX share price rose by 40.85% over the past 1 year
What Is Vertex Pharmaceuticals 52-Week High & Low?
-
What Is Vertex Pharmaceuticals’s 52-Week High Share Price?
Vertex Pharmaceuticals has traded as high as $324.75 over the past 52 weeks -
What Is Vertex Pharmaceuticals’s 52-Week Low Share Price?
Vertex Pharmaceuticals has traded as low as $225.28 over the past 52 weeks
Vertex Pharmaceuticals Price To Free Cash Flow
-
Is Vertex Pharmaceuticals Stock Overvalued?
Vertex Pharmaceuticals is trading at a price to free cash flow ratio of 21.76 -
Is Vertex Pharmaceuticals Stock Undervalued?
Vertex Pharmaceuticals EV to Free Cash Flow ratio is 19.05 -
What Is Vertex Pharmaceuticals’s Price Earnings Growth Ratio?
VRTX PEG ratio is 0.49 -
Is Vertex Pharmaceuticals Trading At A Premium To Earnings?
Vertex Pharmaceuticals EV to EBIT ratio is 17.78
Is It Risky To Buy Vertex Pharmaceuticals?
-
How Much Debt Does Vertex Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Vertex Pharmaceuticals Have?
Cash and short term investments quarterly total is $9.8B -
What Is Vertex Pharmaceuticals’s Book Value Per Share?
Book value per share is 50.77
Is Vertex Pharmaceuticals Cash Flow Positive?
-
What Is VRTX Cash Flow From Operations?
Cash flow from operations (TTM) is $4B -
What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$444.1M -
What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$630.7M
Vertex Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
VRTX return on invested capital is 29.49% -
What Is Vertex Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 22.54% -
What Is VRTX Return On Equity?
ROE is a measure of profitability and is 29.49%
Vertex Pharmaceuticals Earnings Date & Stock Price
-
What Is Vertex Pharmaceuticals's Stock Price Today?
A single share of VRTX can be purchased today for 321.45 -
What Is Vertex Pharmaceuticals’s Stock Symbol?
Vertex Pharmaceuticals trades on the S&P500 under the ticker symbol: VRTX -
When Is Vertex Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Vertex Pharmaceuticals is scheduled on February 7, 2023 -
When Is VRTX's next ex-dividend date?
Vertex Pharmaceuticals's next ex-dividend date is January 28, 2023 -
How To Buy Vertex Pharmaceuticals Stock?
You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Vertex Pharmaceuticals Competitors
-
Who Are Vertex Pharmaceuticals's Competitors?
Below is a list of companies who compete with Vertex Pharmaceuticals or are related in some way:
Vertex Pharmaceuticals Dividend Yield
Data Unavailable
Vertex Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 9.45% | 10.07% |
| Revenue: | 17.65% | 4.82% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 11 |
| Sell Recommendations: | 0 |
| Price Target: | 328.17 |
| Upside from Last Price: | 2.09% |